Investors Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
First quarter 2018 results announcement
On Wednesday 25 April we will announce our first quarter results for the period ended 31 March 2018.
Following the announcement there will be an audio webcast, including a Q&A session, hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer and Luke Miels, President, Global Pharmaceuticals.
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business
On Tuesday 27 March, we announced that GSK has reached an agreement with Novartis to buyout Novartis’s 36.5% stake in the Consumer Healthcare Joint Venture for $13 billion (£9.2 billion).
The press release is available here and materials from a call for investors and analysts are available below.